The effect of allopurinol on serum uric acid levels in patients with diabetic nephropathy; a systematic review and meta-analysis on randomized clinical trials
Authors:
- Jafar KolahiJKJafar Kolahi
- Soleyman AlivandSASoleyman Alivand
- Noorbakhsh AlivandNANoorbakhsh Alivand
- Sara DehghanSDSara Dehghan
- Farzaneh Barkhordari AhmadiFAFarzaneh Barkhordari Ahmadi
- Najmeh ParsaiNPNajmeh Parsai
- Mohammad Hossein TaklifMTMohammad Hossein Taklif
- Reyhaneh SadeghianRSReyhaneh Sadeghian
- Hossein MardanparvarHMHossein Mardanparvar
Open Access
- 1 January 2023
- journal article
- review article
- Published by Maad Rayan Publishing Company in Journal of Renal Endocrinology
- Vol. 9 (1) , e25094
Abstract
Introduction: The correlation between hyperuricemia and chronic kidney disease (CKD) is an approval issue; this study aimed to evaluate the effect of allopurinol on serum uric acid levels in patients with diabetic nephropathy, with the review of randomized clinical trials (RCTs). Materials and Methods: This meta-analysis study was conducted on RCTs in diabetic nephropathy patients, which evaluated the effect of allopurinol on serum uric acid levels. Data were collected by searching international databases and Google Scholar search engines until May 2023. STATA 14 software and the random effects model were conducted to analyze the data. A P value less than 0.05 was considered significant. Results: In this study, five studies with a sample size of 942 patients were assessed. The effect of allopurinol on serum uric acid in comparison to the placebo group deduced that the standard mean difference between the allopurinol group and placebo group was -1.55 mg/dL, which was statistically significant (CI: -2.07 to -1.02). Conclusion: Allopurinol through its uric acid lowering effect would be beneficial for patients with diabetic nephropathy in preventing the progression of CKD. Registration: This study has been compiled based on the PRISMA checklist, and its protocol was registered on the PROSPERO website (ID: CRD42023412051).Keywords
This publication has 18 references indexed in Scilit:
- Effects of allopurinol on renal function in patients with diabetes: a systematic review and meta-analysisRenal Failure, 2022
- Something Old, Something New: the ACR Gout Treatment Guideline and Its Evolution from 2012 to 2020Current Rheumatology Reports, 2020
- Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 DiabetesNew England Journal of Medicine, 2020
- Diabetic kidney diseases revisited: A new perspective for a new eraMolecular Metabolism, 2019
- Effects of febuxostat on renal function in patients with chronic kidney diseaseMedicine, 2019
- Epigenetics and epigenomics in diabetic kidney disease and metabolic memoryNature Reviews Nephrology, 2019
- Hyperuricemia contributes to the faster progression of diabetic kidney disease in type 2 diabetes mellitusJournal of Diabetes and its Complications, 2016
- Allopurinol treatment improves renal function in patients with type 2 diabetes and asymptomatic hyperuricemia: 3‐year randomized parallel‐controlled studyClinical Endocrinology, 2014
- Improving cardiovascular and renal outcomes in gout: what should we target?Nature Reviews Rheumatology, 2014
- Uric Acid as a Mediator of Diabetic NephropathySeminars in Nephrology, 2011